What is the value of your company? Our expert consultants can help you to prepare for your next investment round with an independent valuation.
The typical capital investment process includes a negotiation between the company and the possible investor. It can be challenging to determine a product or company value, especially when it comes to high-risk product development. For example, the development of drug therapies or medical technology products requires a large amount of funding and comes with a high development risk. The translation of complex valuation-dependent factors, such as risk or time, requires the expertise of financial professionals that have broad experience in the life sciences field. The valuation experts at Catalyze provide both companies and investors independent company or product valuation reports.
Read the key service features below.
Eight years ago, Jan Smeitink looked at himself in the mirror and decided he was ...
AMT Medical CEO Rutger Tulleken and Catalyze have an age-old collaboration dating ...
We perform an in-depth interview to gather information about the company, including team, product(s), R&D strategy, target markets, patents, collaborators and financial forecasts. Eventually this information will form the basis for the valuation calculations in the next phase.
We will analyze the information gathered in the first phase and perform additional market, product, and company risk analyses to develop a clear business case. Together with the client we discuss key assumptions for the value calculation. All information is organized and used to calculate a valuation range for the company.
By the end of the collaboration, we provide a tailor-made valuation report that includes all analysis components and the value calculation. This report can be used to strengthen your negotiation position for your next investment round.
The Catalyze team is ready to answer all your questions about Independent Valuations. Simply fill in the form or chat directly with one of our people.